Medicine Regulators have already admitted that COVID vaccination can
cause damage to the heart muscle and lead to cardiovascular
complications such as heart failure, myocarditis, or pericarditis.
But
what they failed to tell the public in December 2020, is that
scientists proved the spike protein, of which the Covid-19 vaccines
instructs your cells to manufacture millions of, crosses the blood-brain
barrier with potentially devastating consequences such as the potential
to cause strokes, Alzheimer’s disease, Parkinson’s disease, Multiple
Sclerosis, and a range of autoimmune disorders.
While mRNA
vaccines have been in development for years, they had never been used on
a large scale in the general population prior to December 2020, when
the Pfizer-BioNTech and Moderna COVID-19 vaccines were granted emergency
use authorization by regulatory agencies.
This is in contrast
to traditional vaccines, which typically use a weakened or inactivated
form of a virus to trigger an immune response. Traditional vaccines have
been used for many decades and have an alleged long track record of
safety and efficacy.
The main factor that contributed to the
delayed use of mRNA vaccines on a large scale prior to December 2020 is
the risk of antibody-dependent enhancement (ADE).
ADE is a
phenomenon where a previous infection or vaccination can lead to a more
severe form of the disease upon subsequent exposure. In the case of
COVID-19, there were concerns that vaccination with an mRNA vaccine
could trigger ADE and make the disease worse in people who were
vaccinated.
Despite this, the Pfizer-BioNTech COVID-19 vaccine,
an mRNA injection that is supposedly designed to provide protection
against the alleged SARS-CoV-2 virus, which causes COVID-19, was granted
Emergency Use Authorisation (EUA) in early December 2020.
The
injection works by using a small piece of the alleged virus’s genetic
material, known as messenger RNA (mRNA), which instructs cells in your
body to produce a piece of the virus called the spike (S) protein.
The
spike protein then triggers an immune response, which teaches the
immune system to recognize and fight the alleged virus if a person is
later exposed to it.
However, just days after the Pfizer
vaccine was granted Emergency Use Authorisation, several scientists
published a study, on the 16th of December 2020, proving the S protein
of SARS-CoV-2 crosses the blood-brain barrier in mice...<<<Read More>>>...